1-氨基-5-氯萘 | 2750-80-3

• 物质功能分类: 有机原料 - 烃类化合物及其衍生物 - 芳香烃
• 分子结构分类: 有机化合物 - 苯类化合物 - 萘
• 中文名称: 1-氨基-5-氯萘
• 中文别名: 5-氯萘-1-胺
• 英文名称: 1-amino-4-chloronaphthalene
• 英文别名: 5-chloronaphthalen-1-amine；5-chloro-[1]naphthylamine；5-Chlor-[1]naphthylamin；5-Chlor-1-amino-naphthalin；1-Amino-5-chloronaphthalene；5-chloro-1-naphthylamine
• CAS: 2750-80-3
• 化学式: C₁₀H₈ClN
• mdl: MFCD01026464
• 分子量: 177.633
• InChiKey: JRFLIJXBMJNZQP-UHFFFAOYSA-N

物化性质

• 熔点：
  85 °C(Solv: ethanol (64-17-5))
• 沸点：
  336.4±17.0 °C(Predicted)
• 密度：
  1.289±0.06 g/cm3(Predicted)
• 溶解度：
  可溶于氯仿（少许）、甲醇（少许）

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  12
• 可旋转键数：
  0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921450090
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 5-Chloronaphthalen-1-amine
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 5-Chloronaphthalen-1-amine
CAS number: 2750-80-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels, refrigerated.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C10H8ClN
Molecular weight: 177.6

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, hydrogen chloride.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  1-氨基-5-氯萘 在 盐酸 、 sodium tetrahydroborate 、 copper(l) iodide 、 四(三苯基膦)钯 、 1,1'-双(二苯膦基)二茂铁二氯化钯(II)二氯甲烷复合物 、 乙醇 、 溴 、 sodium hydride 、 R-(+)-1,1'-联萘-2,2'-双二苯膦 、 溶剂黄146 、 丙酸 、 sodium nitrite 作用下， 以 四氢呋喃 、 1,4-二氧六环 、 甲醇 、 氯仿 、 甲苯 为溶剂， 反应 30.5h， 生成 4-(4-(3,8-diazabicyclo[3.2.1]octan-3-yl)-8-fluoro-2-((tetrahydro-1H-pyrrolizin-7a(5H)-yl)methoxy)pyrido[4,3-d]pyrimidin-7-yl)-5-chloronaphthalen-2-ol
  参考文献：
  名称：

  [EN] KRAS G12D INHIBITORS
  [FR] INHIBITEURS DE KRAS G12D

  摘要：

  本发明涉及抑制KRas G12D的化合物。具体地，本发明涉及抑制KRas G12D活性的化合物，包括这些化合物的药物组合物以及使用方法。

  公开号：

  WO2021041671A1
• 作为产物：
  描述：

  5-溴-1-硝基-萘 在 盐酸 、 tris-(dibenzylideneacetone)dipalladium(0) 、 5%-palladium/activated carbon 、 氢气 、 caesium carbonate 、 4,5-双二苯基膦-9,9-二甲基氧杂蒽 、 sodium nitrite 作用下， 以 1,4-二氧六环 、 水 、 乙酸乙酯 、 N,N-二甲基甲酰胺 为溶剂， 反应 7.5h， 生成 1-氨基-5-氯萘
  参考文献：
  名称：

  [EN] QUINAZOLINE COMPOUNDS, PREPARATION METHODS AND USES THEREOF
  [FR] COMPOSÉS DE QUINAZOLINE, LEURS PROCÉDÉS DE PRÉPARATION ET LEURS UTILISATIONS

  摘要：

  本文提供了新颖的化合物，例如具有化学式(I)、化学式(II)或化学式(III)的化合物，或其药用可接受的盐。本文还提供了制备这些化合物的方法以及使用这些化合物的方法，例如，在癌细胞中抑制KRAS G12D，以及治疗各种癌症，如胰腺癌、结肠癌、肺癌或子宫内膜癌。

  公开号：

  WO2022002102A1

文献信息

• Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function
  申请人：——

  公开号：US20040077605A1

  公开（公告）日：2004-04-22

  Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

  融合的环化合物，使用这种化合物治疗与核激素受体相关的疾病，如癌症和免疫紊乱的方法，以及含有这种化合物的药物组合物。
• METHOD FOR THE PREPARATION OF FUSED HETEROCYCLIC SUCCINIMIDE COMPOUNDS AND ANALOGS THEREOF
  申请人：Salvati E. Mark

  公开号：US20050119228A1

  公开（公告）日：2005-06-02

  Fused cyclic compounds, methods of using such compounds in the treatment of nuclear hormone receptor-associated conditions such as cancer and immune disorders, and pharmaceutical compositions containing such compounds.

  融合的环化合物，使用这种化合物治疗与核激素受体相关的疾病，如癌症和免疫紊乱的方法，以及含有这种化合物的药物组合物。
• Direct Cyanation of Picolinamides Using K₄[Fe(CN)₆] as the Cyanide Source
  作者：Dinghui Guan、Lu Han、Lulu Wang、He Song、Wenyi Chu、Zhizhong Sun

  DOI：10.1246/cl.150111

  日期：2015.6.5

  The efficient, simple, and environment-friendly route of direct cyanation of picolinamides has been developed with nontoxic K4[Fe(CN)6] as the cyanide source through Pd-catalyzed C–H bond activatio...

  以无毒的K4[Fe(CN)6]为氰化物源，通过Pd催化的C-H键活化，开发了一种高效、简单、环保的吡啶甲酰胺直接氰化路线。
• Pd-catalyzed direct CH cyanation of picolinamides via bidentate chelation assistance
  作者：Lulu Wang、Minxin Yang、Xiaochong Liu、He Song、Lu Han、Wenyi Chu、Zhizhong Sun

  DOI：10.1002/aoc.3489

  日期：2016.8

  A bidentate‐chelation assistant palladium‐catalyzed direct C‐H cyanation of picolinamides with TMSCN is described. The reaction of various derivatives gave the corresponding cyanated products in moderate to good yields under mild conditions. In addition, the cyanated product could transform into some valuable functional groups in good yields. Copyright © 2016 John Wiley & Sons, Ltd.

  描述了用TMSCN的二齿螯合助剂钯催化的吡啶甲酰胺直接C-H氰化。各种衍生物的反应在温和条件下以中等至良好的产率得到了相应的氰化产物。另外，氰化产物可以高产率转化成一些有价值的官能团。版权所有©2016 John Wiley＆Sons，Ltd.
• Scaffold Hopping from Amodiaquine to Novel Nurr1 Agonist Chemotypes via Microscale Analogue Libraries
  作者：Sabine Willems、Marcel Müller、Julia Ohrndorf、Jan Heering、Ewgenij Proschak、Daniel Merk

  DOI：10.1002/cmdc.202200026

  日期：2022.4.20

  nuclear receptor Nurr1 is considered a neuroprotective transcription factor and ascribed high therapeutic potential, but Nurr1 activators are rare. Using the Nurr1 agonist amodiaquine as starting point, microscale analogue libraries were synthesized and tested in a cellular setting to identify new Nurr1 ligand scaffolds. Thereby, novel synthetic Nurr1 activators exceeding amodiaquine in potency were

  核受体Nurr1 被认为是一种神经保护性转录因子，具有很高的治疗潜力，但 Nurr1 激活剂很少见。以 Nurr1 激动剂阿莫地喹为起点，合成微型类似物文库并在细胞环境中进行测试，以鉴定新的 Nurr1 配体支架。由此，获得了效力超过阿莫地喹的新型合成Nurr1激活剂。